Business Context and Reporting Period
This Form 8-K is a current report filed by BioSig Technologies, Inc. (not Streamex Corp.) on November 18, 2019. The filing details the results of the Company's 2019 Annual Meeting of Stockholders held on the same date. The Company is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM.
Key Financial Metrics
This filing is a corporate governance report and does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. No financial statements are included in this document.
Material Changes and Voting Results
The filing reports the successful passage of five proposals at the Annual Meeting:
- Director Elections: All nine nominees were elected to the Board of Directors for a one-year term. Notable vote counts included Kenneth L. Londoner (10,943,124 votes for) and Jeffrey F. O'Donnell, Sr. (10,383,653 votes for).
- Equity Plan Amendment: Stockholders approved the Seventh Amendment to the 2012 Equity Incentive Plan, increasing the share reserve by 2,000,000 shares to a total of 9,474,450 shares available for issuance.
- Executive Compensation: An advisory vote on executive compensation was approved with 9,613,744 votes in favor.
- Compensation Frequency: Stockholders voted to hold future advisory votes on executive compensation every three years (8,683,068 votes).
- Auditor Ratification: The appointment of Liggett & Webb, P.A. as the independent registered public accounting firm for the 2019 fiscal year was ratified with 17,269,321 votes in favor.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future financial guidance, operational outlook, or specific risk factors. The document strictly reports on the procedural outcomes of the Annual Meeting and incorporates by reference the 2019 Proxy Statement for further details on the matters voted upon.
Investor Verification Checklist
- Verify the total number of shares authorized under the amended 2012 Equity Incentive Plan (9,474,450 shares).
- Review the 2019 Proxy Statement for detailed biographies of the newly elected directors and the specific terms of the equity plan amendment.
- Confirm the voting thresholds met for the advisory compensation votes, noting the significant number of broker non-votes (6,442,444) on certain proposals.
- Check subsequent filings for the Company's actual financial performance, as this 8-K contains no financial data.